Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Obstructive Lung Diseases

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 137 articles:
HTML format

Single Articles

    January 2022
  1. KUMARI MV, Amarasiri L, Rajindrajith S, Devanarayana NM, et al
    Gastric motility and pulmonary function in children with functional abdominal pain disorders and asthma: A pathophysiological study.
    PLoS One. 2022;17:e0262086.
    PubMed     Abstract available

  2. MULUGETA T, Ayele T, Zeleke G, Tesfay G, et al
    Asthma control and its predictors in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0262566.
    PubMed     Abstract available

  3. ROH JH, Lee H, Yun-Jeong B, Park CS, et al
    A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults.
    PLoS One. 2022;17:e0262715.
    PubMed     Abstract available

  4. CELIK E, Nelles C, Kottlors J, Fervers P, et al
    Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection.
    PLoS One. 2022;17:e0263261.
    PubMed     Abstract available

  5. MCNAMARA PS, Clayton D, Burchett C, Compton V, et al
    Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial.
    PLoS One. 2022;17:e0263044.
    PubMed     Abstract available

  6. HAMZEH H, Spencer S, Kelly C
    Development of a core outcome set and outcome measurement set for physiotherapy trials in adults with Bronchiectasis (COS-PHyBE study): A protocol.
    PLoS One. 2022;17:e0263695.
    PubMed     Abstract available

  7. KNUDSEN KS, Lehmann S, Nielsen R, Tangedal S, et al
    The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    PLoS One. 2022;17:e0262082.
    PubMed     Abstract available

  8. REINHART JM, de Oliveira GAR, Forsythe L, Li Z, et al
    Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.
    PLoS One. 2022;17:e0262336.
    PubMed     Abstract available

  9. BAKSHI A, Van Doren A, Maser C, Aubin K, et al
    Identifying Louisiana communities at the crossroads of environmental and social vulnerability, COVID-19, and asthma.
    PLoS One. 2022;17:e0264336.
    PubMed     Abstract available

  10. HERAGANAHALLY SS, Howarth T, Sorger L, Ben Saad H, et al
    Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease.
    PLoS One. 2022;17:e0263744.
    PubMed     Abstract available

  11. SAIPHOKLANG N, Pugongchai A, Leelasittikul K
    Comparison between 20 and 30 meters in walkway length affecting the 6-minute walk test in patients with chronic obstructive pulmonary disease: A randomized crossover study.
    PLoS One. 2022;17:e0262238.
    PubMed     Abstract available

  12. AUGUSTIN IML, Franssen FME, Houben-Wilke S, Janssen DJA, et al
    Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients.
    PLoS One. 2022;17:e0263657.
    PubMed     Abstract available

  13. WEN S, Yuan G, Li C, Xiong Y, et al
    High cellulose dietary intake relieves asthma inflammation through the intestinal microbiome in a mouse model.
    PLoS One. 2022;17:e0263762.
    PubMed     Abstract available

  14. MARCALO R, Neto S, Pinheiro M, Rodrigues AJ, et al
    Evaluation of the genetic risk for COVID-19 outcomes in COPD and differences among worldwide populations.
    PLoS One. 2022;17:e0264009.
    PubMed     Abstract available

  15. WINNICA DE, Monzon A, Ye S, Vladar EK, et al
    Airway epithelial Paraoxonase-2 in obese asthma.
    PLoS One. 2022;17:e0261504.
    PubMed     Abstract available

  16. HYODO K, Masuko H, Oshima H, Shigemasa R, et al
    Common exacerbation-prone phenotypes across asthma and chronic obstructive pulmonary disease (COPD).
    PLoS One. 2022;17:e0264397.
    PubMed     Abstract available

  17. BUSHONG A, McKeon T, Regina Boland M, Field J, et al
    Publicly available data reveals association between asthma hospitalizations and unconventional natural gas development in Pennsylvania.
    PLoS One. 2022;17:e0265513.
    PubMed     Abstract available

  18. SUNDH J, Palm A, Wahlberg J, Runold M, et al
    Impact of covid-19 on long-term oxygen therapy 2020: A nationwide study in Sweden.
    PLoS One. 2022;17:e0266367.
    PubMed     Abstract available

  19. CAVALCANTI JD, Fregonezi GAF, Sarmento AJ, Bezerra T, et al
    Electrical activity and fatigue of respiratory and locomotor muscles in obstructive respiratory diseases during field walking test.
    PLoS One. 2022;17:e0266365.
    PubMed     Abstract available

  20. JEGANATHAN V, Knight S, Bricknell M, Ridgers A, et al
    Impact of smoking status and chronic obstructive pulmonary disease on pulmonary complications post lung cancer surgery.
    PLoS One. 2022;17:e0266052.
    PubMed     Abstract available

  21. ZHANG C, Li W, Li X, Wan D, et al
    Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor.
    PLoS One. 2022;17:e0266608.
    PubMed     Abstract available

  22. STEVENS DR, Rohn MCH, Hinkle SN, Williams AD, et al
    Maternal body composition and gestational weight gain in relation to asthma control during pregnancy.
    PLoS One. 2022;17:e0267122.
    PubMed     Abstract available

  23. CASSELBRANT A, Fedorowski A, Frantz S, Engstrom G, et al
    Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease.
    PLoS One. 2022;17:e0264376.
    PubMed     Abstract available

  24. SVENDSEN CD, Kuiper KKJ, Ostridge K, Larsen TH, et al
    Factors associated with coronary heart disease in COPD patients and controls.
    PLoS One. 2022;17:e0265682.
    PubMed     Abstract available

  25. ASHEBIR G, Nigussie H, Glagn M, Beyene K, et al
    Determinants of hyperemesis gravidarum among pregnant women attending health care service in public hospitals of Southern Ethiopia.
    PLoS One. 2022;17:e0266054.
    PubMed     Abstract available

  26. CHAN AHY, Foot H, Pearce CJ, Horne R, et al
    Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0265715.
    PubMed     Abstract available

  27. KASO AW, Agero G, Hurissa Z, Kaso T, et al
    Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study.
    PLoS One. 2022;17:e0268280.
    PubMed     Abstract available

  28. FUTAMURA M, Hiramitsu Y, Kamioka N, Yamaguchi C, et al
    Prevalence of infantile wheezing and eczema in a metropolitan city in Japan: A complete census survey.
    PLoS One. 2022;17:e0268092.
    PubMed     Abstract available

  29. KOLDEWEIJ C, Appelbaum N, Rodriguez Gonzalvez C, Nijman J, et al
    Mind the gap: Mapping variation between national and local clinical practice guidelines for acute paediatric asthma from the United Kingdom and the Netherlands.
    PLoS One. 2022;17:e0267445.
    PubMed     Abstract available

  30. HOFER F, Schreyogg J, Stargardt T
    Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany: Evidence from the first three years.
    PLoS One. 2022;17:e0267952.
    PubMed     Abstract available

  31. MARTINSEN EMH, Eagan TML, Wiker HG, Leiten EO, et al
    A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease.
    PLoS One. 2022;17:e0267195.
    PubMed     Abstract available

    Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.
    PLoS One. 2022;17:e0268772.
    PubMed     Abstract available

  33. PEROSSI L, Holtz M, Santos DOD, Perossi J, et al
    Increased airway resistance can be related to the decrease in the functional capacity in obese women.
    PLoS One. 2022;17:e0267546.
    PubMed     Abstract available

  34. MAJELLANO EC, Clark VL, McLoughlin RF, Gibson PG, et al
    Using a knowledge translation framework to identify health care professionals' perceived barriers and enablers for personalised severe asthma care.
    PLoS One. 2022;17:e0269038.
    PubMed     Abstract available

  35. PATEL P, Muhammad T, Sahoo H
    Morbidity status and changes in difficulty in activities of daily living among older adults in India: A panel data analysis.
    PLoS One. 2022;17:e0269388.
    PubMed     Abstract available

  36. FENG S, Yuan J, Zhao D, Li R, et al
    Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology.
    PLoS One. 2022;17:e0269087.
    PubMed     Abstract available

  37. KHDOUR M, Abu Ghayyadeh M, Al-Hamed D, Alzeerelhouseini H, et al
    Assessment of quality of life in asthmatic children and adolescents: A cross sectional study in West Bank, Palestine.
    PLoS One. 2022;17:e0270680.
    PubMed     Abstract available

  38. EVOY R, Kincl L, Rohlman D, Bramer LM, et al
    Impact of acute temperature and air pollution exposures on adult lung function: A panel study of asthmatics.
    PLoS One. 2022;17:e0270412.
    PubMed     Abstract available

  39. PEROSSI J, Koenigkam-Santos M, Perossi L, Dos Santos DO, et al
    Correlation among clinical, functional and morphological indexes of the respiratory system in non-cystic fibrosis bronchiectasis patients.
    PLoS One. 2022;17:e0269897.
    PubMed     Abstract available

  40. HUANG WC, Fox GJ, Pham NY, Nguyen TA, et al
    Stepped treatment algorithm using budesonide-formoterol for chronic respiratory diseases: A single arm interventional study.
    PLoS One. 2022;17:e0271178.
    PubMed     Abstract available

  41. GUO IE H, Tang CH, Sheu ML, Liu HY, et al
    Evaluation of risk adjustment performance of diagnosis-based and medication-based comorbidity indices in patients with chronic obstructive pulmonary disease.
    PLoS One. 2022;17:e0270468.
    PubMed     Abstract available

  42. LEE HJ, Kim SK, Lee JW, Im SA, et al
    Quantitative CT lung densitometry as an obstructive marker for the diagnosis of bronchiolitis obliterans in children.
    PLoS One. 2022;17:e0271135.
    PubMed     Abstract available

  43. RAJAPAKSE S, Wickramasinghe N, Warnasekara J, Abeyrathna P, et al
    Asthma in a prospective cohort of rural pregnant women from Sri Lanka: Need for better care during the pre-conceptional and antenatal period.
    PLoS One. 2022;17:e0269888.
    PubMed     Abstract available

  44. FIGUEIREDO RG, Pinheiro GP, Arata V, Leal MFM, et al
    Impact of frailty in elderly patients with moderate to severe asthma.
    PLoS One. 2022;17:e0270921.
    PubMed     Abstract available

  45. CALLI E, Murphy K, Scholten ET, Schalekamp S, et al
    Explainable emphysema detection on chest radiographs with deep learning.
    PLoS One. 2022;17:e0267539.
    PubMed     Abstract available

  46. GUO YG, Zhang Y, Liu WL
    The causal relationship between allergic diseases and heart failure: Evidence from Mendelian randomization study.
    PLoS One. 2022;17:e0271985.
    PubMed     Abstract available

  47. YOSHIDA M, Hiramoto T, Moriwaki A, Osoreda H, et al
    Impact of extrapulmonary comorbidities on physical activity in chronic obstructive pulmonary disease in Japan: A cross-sectional study.
    PLoS One. 2022;17:e0270836.
    PubMed     Abstract available

  48. VIGORE M, Granata N, Braga SS, Piaggi G, et al
    Cognitive impairment, frailty and rehabilitation outcome in older cardiorespiratory patients. DEC_FRAinRIAB: Study protocol.
    PLoS One. 2022;17:e0272132.
    PubMed     Abstract available

  49. TOPAZ M, Zolnoori M, Norful AA, Perrier A, et al
    Speech recognition can help evaluate shared decision making and predict medication adherence in primary care setting.
    PLoS One. 2022;17:e0271884.
    PubMed     Abstract available

  50. HARUN-OR-ROSHID M, Ali MB, Jesmin, Mollah MNH, et al
    Association of hypoxia inducible factor 1-Alpha gene polymorphisms with multiple disease risks: A comprehensive meta-analysis.
    PLoS One. 2022;17:e0273042.
    PubMed     Abstract available

  51. SILER TM, Jain R, Collison K, Sharma R, et al
    Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease.
    PLoS One. 2022;17:e0273170.
    PubMed     Abstract available

  52. HUANG SY, Hsu CM, Yang YH, Tsai YH, et al
    Elevated risk of acute epiglottitis in patients with chronic obstructive pulmonary disease: A nationwide cohort study.
    PLoS One. 2022;17:e0273437.
    PubMed     Abstract available

  53. SHARMA BB, Singh S, Sharma KK, Sharma AK, et al
    Proportionate clinical burden of respiratory diseases in Indian outdoor services and its relationship with seasonal transitions and risk factors: The results of SWORD survey.
    PLoS One. 2022;17:e0268216.
    PubMed     Abstract available

  54. LAUNDERS N, Dotsikas K, Marston L, Price G, et al
    The impact of comorbid severe mental illness and common chronic physical health conditions on hospitalisation: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272498.
    PubMed     Abstract available

  55. ANGELAKIS L, Papaioannou AI, Papathanasiou E, Mazioti A, et al
    Sestrin 2 levels are associated with emphysematous phenotype of COPD.
    PLoS One. 2022;17:e0273652.
    PubMed     Abstract available

  56. BELL N, Lopez-De Fede A, Cai B, Brooks J, et al
    Geographic proximity to primary care providers as a risk-assessment criterion for quality performance measures.
    PLoS One. 2022;17:e0273805.
    PubMed     Abstract available

  57. ALENAZY MF, Sharif-Askari FS, El-Wetidy MS, Sharif-Askari NS, et al
    Intranasal administration of abatacept enhances IL-35+ and IL-10+ producing Bregs in lung tissues of ovalbumin-sensitized asthmatic mice model.
    PLoS One. 2022;17:e0271689.
    PubMed     Abstract available

  58. OWUSUAA C, van Lent LGG, van 't Spijker A, van der Rijt CCD, et al
    Discussing prognosis and the end of life with patients with advanced cancer or COPD: A qualitative study.
    PLoS One. 2022;17:e0274201.
    PubMed     Abstract available

  59. AU-DOUNG PLW, Wong CKM, Chan DCC, Chung JWH, et al
    PUMA screening tool to detect COPD in high-risk patients in Chinese primary care-A validation study.
    PLoS One. 2022;17:e0274106.
    PubMed     Abstract available

  60. SIGNES-PASTOR AJ, Diaz-Coto S, Martinez-Camblor P, Carey M, et al
    Arsenic exposure and respiratory outcomes during childhood in the INMA study.
    PLoS One. 2022;17:e0274215.
    PubMed     Abstract available

  61. HAAS-NEIL S, Dvorkin-Gheva A, Forsythe P
    Severe, but not moderate asthmatics share blood transcriptomic changes with post-traumatic stress disorder and depression.
    PLoS One. 2022;17:e0275864.
    PubMed     Abstract available

  62. IMRAISH A, Abu-Thiab T, Alhindi T, Zihlif M, et al
    GSDM gene polymorphisms regulate the IgE level in asthmatic patients.
    PLoS One. 2022;17:e0274951.
    PubMed     Abstract available

  63. O'HOSKI S, Kuspinar A, Wald J, Richardson J, et al
    People with COPD have greater participation restrictions than age-matched older adults without respiratory conditions assessed during the COVID-19 pandemic.
    PLoS One. 2022;17:e0275264.
    PubMed     Abstract available

  64. BANAGANAPALLI B, Mallah B, Alghamdi KS, Albaqami WF, et al
    Integrative weighted molecular network construction from transcriptomics and genome wide association data to identify shared genetic biomarkers for COPD and lung cancer.
    PLoS One. 2022;17:e0274629.
    PubMed     Abstract available

  65. SHIMODA M, Tanaka Y, Morimoto K, Abe T, et al
    Analysis of predicted factors for bronchoalveolar lavage recovery failure: An observational study.
    PLoS One. 2022;17:e0275377.
    PubMed     Abstract available

  66. KONDO R, Maeda S, Kikuchi A, Kiyono H, et al
    Optimal follow-up period after switching to another inhaled corticosteroid/long-acting beta2 agonist in patients with asthma: A retrospective study using Japanese administrative claims data.
    PLoS One. 2022;17:e0276001.
    PubMed     Abstract available

  67. HORNDAHL J, Svard R, Berntsson P, Wingren C, et al
    HDAC6 inhibitor ACY-1083 shows lung epithelial protective features in COPD.
    PLoS One. 2022;17:e0266310.
    PubMed     Abstract available

  68. PERAKYLA L, Nykanen A, Piilonen A, Kesavuori R, et al
    Transition from BOS to RAS impairs prognosis after lung transplantation-CLAD subtype analysis by CT volumetry.
    PLoS One. 2022;17:e0275563.
    PubMed     Abstract available

  69. MIKOLAIZAK AS, Rochester L, Maetzler W, Sharrack B, et al
    Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol.
    PLoS One. 2022;17:e0269615.
    PubMed     Abstract available

  70. VEENSTRA P, Veeger NJGM, Koppers RJH, Duiverman ML, et al
    High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study.
    PLoS One. 2022;17:e0272372.
    PubMed     Abstract available

  71. PARKER SJ, DeLaroche AM, Hill AB, Arora R, et al
    Influenza vaccination coverage among an urban pediatric asthma population: Implications for population health.
    PLoS One. 2022;17:e0269415.
    PubMed     Abstract available

  72. SHAIK NA, Nasser K, Mohammed A, Mujalli A, et al
    Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches.
    PLoS One. 2022;17:e0271262.
    PubMed     Abstract available

  73. WATSON DE, Marashi-Pour S, Tran B, Witchard A, et al
    Patient-reported experiences and outcomes following hospital care are associated with risk of readmission among adults with chronic health conditions.
    PLoS One. 2022;17:e0276812.
    PubMed     Abstract available

  74. URUMA Y, Manabe T, Fujikura Y, Iikura M, et al
    Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276774.
    PubMed     Abstract available

  75. GAREIS H, Horner-Schmid L, Zablotski Y, Palic J, et al
    Evaluation of barometric whole-body plethysmography for therapy monitoring in cats with feline lower airway disease.
    PLoS One. 2022;17:e0276927.
    PubMed     Abstract available

  76. LIAO S, Song C, Wang X, Wang Y, et al
    A classification framework for identifying bronchitis and pneumonia in children based on a small-scale cough sounds dataset.
    PLoS One. 2022;17:e0275479.
    PubMed     Abstract available

  77. DOS SANTOS CF, Braz MG, de Arruda NM, Caram L, et al
    DNA damage and antioxidant capacity in COPD patients with and without lung cancer.
    PLoS One. 2022;17:e0275873.
    PubMed     Abstract available

  78. LISBOA RO, Sekula RF, Bezamat M, Deeley K, et al
    Pain perception genes, asthma, and oral health: A reverse genetics study.
    PLoS One. 2022;17:e0277036.
    PubMed     Abstract available

  79. LEITER A, Kong CY, Gould MK, Kale MS, et al
    The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study.
    PLoS One. 2022;17:e0263911.
    PubMed     Abstract available

  80. BREULS S, Pereira de Araujo C, Blondeel A, Yserbyt J, et al
    Physical activity pattern of patients with interstitial lung disease compared to patients with COPD: A propensity-matched study.
    PLoS One. 2022;17:e0277973.
    PubMed     Abstract available

  81. ZHENG J, Zhang Z, Han R, Zhang H, et al
    Effects of exercise-based home pulmonary rehabilitation on patients with chronic obstructive pulmonary disease: An overview of systematic review.
    PLoS One. 2022;17:e0277632.
    PubMed     Abstract available

  82. ABE T, Yoshida N, Shimada T, Nakashima M, et al
    Respiratory frequency-tunable dynamic imaging for lung function: New exam method using chest X-ray cine imaging considering various respiratory diseases.
    PLoS One. 2022;17:e0276859.
    PubMed     Abstract available

    January 2021
  83. OVASKAINEN K, Ojala R, Gissler M, Luukkaala T, et al
    Is birth out-of-hospital associated with mortality and morbidity by seven years of age?
    PLoS One. 2021;16:e0250163.
    PubMed     Abstract available

  84. CHIU YC, Lee SW, Liu CW, Lin RC, et al
    Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity.
    PLoS One. 2021;16:e0249944.
    PubMed     Abstract available

  85. DAWICKI W, Huang H, Ma Y, Town J, et al
    CD40 signaling augments IL-10 expression and the tolerogenicity of IL-10-induced regulatory dendritic cells.
    PLoS One. 2021;16:e0248290.
    PubMed     Abstract available

  86. XIE Z, Sun H, Li X, Sun W, et al
    Alteration of lung tissues proteins in birch pollen induced asthma mice before and after SCIT.
    PLoS One. 2021;16:e0258051.
    PubMed     Abstract available

  87. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed     Abstract available

  88. GE E, Li Y, Wu S, Candido E, et al
    Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    PLoS One. 2021;16:e0258154.
    PubMed     Abstract available

  89. STOFFELS AAF, van den Borst B, Peters JB, Klaassen MPM, et al
    Correlates of variability in endurance shuttle walk test time in patients with chronic obstructive pulmonary disease.
    PLoS One. 2021;16:e0249786.
    PubMed     Abstract available

  90. THAPAMAGAR SB, Ellstrom K, Anholm JD, Fargo RA, et al
    Impact of pulmonary rehabilitation in sleep in COPD patients measured by actigraphy.
    PLoS One. 2021;16:e0248466.
    PubMed     Abstract available

  91. CHANG JT, Meza R, Levy DT, Arenberg D, et al
    Prediction of COPD risk accounting for time-varying smoking exposures.
    PLoS One. 2021;16:e0248535.
    PubMed     Abstract available

  92. CHERNEVA Z, Valev D, Youroukova V, Cherneva R, et al
    Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease - a step forward in cardiovascular comorbidome.
    PLoS One. 2021;16:e0247940.
    PubMed     Abstract available

  93. SHUAI T, Zhang C, Zhang M, Wang Y, et al
    Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251348.
    PubMed     Abstract available

  94. MOHAMED AMINE M, Selma M, Adel S, Khaoula BHA, et al
    2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
    PLoS One. 2021;16:e0251716.
    PubMed     Abstract available

  95. JIANG H, Wu X, Lian S, Zhang C, et al
    Effects of salbutamol on the kinetics of sevoflurane and the occurrence of early postoperative pulmonary complications in patients with mild-to-moderate chronic obstructive pulmonary disease: A randomized controlled study.
    PLoS One. 2021;16:e0251795.
    PubMed     Abstract available

  96. GOFFIN JR, Corriveau S, Tang GH, Pond GR, et al
    Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system.
    PLoS One. 2021;16:e0251886.
    PubMed     Abstract available

  97. HOSKOVEC L, Benka-Coker W, Severson R, Magzamen S, et al
    Model choice for estimating the association between exposure to chemical mixtures and health outcomes: A simulation study.
    PLoS One. 2021;16:e0249236.
    PubMed     Abstract available

  98. LEE J, Lee SH, Gu GJ, Choi JH, et al
    Alterations of lung microbial communities in obese allergic asthma and metabolic potential.
    PLoS One. 2021;16:e0256848.
    PubMed     Abstract available

  99. LAUNAY T, Souty C, Vilcu AM, Turbelin C, et al
    Common communicable diseases in the general population in France during the COVID-19 pandemic.
    PLoS One. 2021;16:e0258391.
    PubMed     Abstract available

  100. ABDUR REHMAN N, Counts S
    Neighborhood level chronic respiratory disease prevalence estimation using search query data.
    PLoS One. 2021;16:e0252383.
    PubMed     Abstract available

  101. NACERADSKA M, Pekova S, Danesi P, Furlanello T, et al
    A novel Filobacterium sp can cause chronic bronchitis in cats.
    PLoS One. 2021;16:e0251968.
    PubMed     Abstract available

  102. HSIEH HY, Huang LC, Yu HR, Kuo KC, et al
    Pediatric thalassemic patients have higher incidence of asthma: A nationwide population-based retrospective cohort study.
    PLoS One. 2021;16:e0258727.
    PubMed     Abstract available

  103. KARAPETYAN S, Schneider A, Linde K, Donnachie E, et al
    SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: A risk assessment based on routine data.
    PLoS One. 2021;16:e0258914.
    PubMed     Abstract available

  104. WICHER SA, Roos BB, Teske JJ, Fang YH, et al
    Aging increases senescence, calcium signaling, and extracellular matrix deposition in human airway smooth muscle.
    PLoS One. 2021;16:e0254710.
    PubMed     Abstract available

  105. NIEMEIER-WALSH C, Ryan PH, Meller J, Ollberding NJ, et al
    Exposure to traffic-related air pollution and bacterial diversity in the lower respiratory tract of children.
    PLoS One. 2021;16:e0244341.
    PubMed     Abstract available

  106. TOUNSI B, Acheche A, Lelard T, Tabka Z, et al
    Effects of specific inspiratory muscle training combined with whole-body endurance training program on balance in COPD patients: Randomized controlled trial.
    PLoS One. 2021;16:e0257595.
    PubMed     Abstract available

  107. FU X, Zhong Y, Xu W, Ju J, et al
    The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review.
    PLoS One. 2021;16:e0256480.
    PubMed     Abstract available

  108. HANSEN WAH, Schlunssen V, Jors E, Sekabojja D, et al
    Precision and accuracy of FEV1 measurements from the Vitalograph copd-6 mini-spirometer in a healthy Ugandan population.
    PLoS One. 2021;16:e0253319.
    PubMed     Abstract available

  109. ROH JA, Kim KI, Jung HJ
    The efficacy of manual therapy for chronic obstructive pulmonary disease: A systematic review.
    PLoS One. 2021;16:e0251291.
    PubMed     Abstract available

  110. NOORT BAC, van der Vaart T, Ahaus K
    Orchestration versus bookkeeping: How stakeholder pressures drive a healthcare purchaser's institutional logics.
    PLoS One. 2021;16:e0258337.
    PubMed     Abstract available

  111. GILLENWATER LA, Helmi S, Stene E, Pratte KA, et al
    Multi-omics subtyping pipeline for chronic obstructive pulmonary disease.
    PLoS One. 2021;16:e0255337.
    PubMed     Abstract available

  112. HALNER A, Beer S, Pullinger R, Bafadhel M, et al
    Predicting treatment outcomes following an exacerbation of airways disease.
    PLoS One. 2021;16:e0254425.
    PubMed     Abstract available

  113. RORTH R, Clausen MF, Fosbol EL, Mogensen UM, et al
    Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
    PLoS One. 2021;16:e0255364.
    PubMed     Abstract available

  114. GIMENO-MIGUEL A, Bliek-Bueno K, Poblador-Plou B, Carmona-Pirez J, et al
    Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study.
    PLoS One. 2021;16:e0259822.
    PubMed     Abstract available

  115. JIANG Y, Hu H, Leung SW
    Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis.
    PLoS One. 2021;16:e0255545.
    PubMed     Abstract available

  116. BOZIGAR M, Lawson AB, Pearce JL, Svendsen ER, et al
    Using Bayesian time-stratified case-crossover models to examine associations between air pollution and "asthma seasons" in a low air pollution environment.
    PLoS One. 2021;16:e0260264.
    PubMed     Abstract available

  117. MACHADO-ALBA JE, Valladales-Restrepo LF, Machado-Duque ME, Gaviria-Mendoza A, et al
    Factors associated with admission to the intensive care unit and mortality in patients with COVID-19, Colombia.
    PLoS One. 2021;16:e0260169.
    PubMed     Abstract available

  118. MONTEIRO KS, Santino TA, Pakhale S, Balfour L, et al
    Translation, cross-cultural adaptation and psychometric evaluation of the Brazilian version of the Cystic Fibrosis Knowledge Scale (CFKS).
    PLoS One. 2021;16:e0259232.
    PubMed     Abstract available

  119. HAKIZIMANA B, Kalimba E, Ndatinya A, Saint G, et al
    Field testing two existing, standardized respiratory severity scores (LIBSS and ReSViNET) in infants presenting with acute respiratory illness to tertiary hospitals in Rwanda - a validation and inter-rater reliability study.
    PLoS One. 2021;16:e0258882.
    PubMed     Abstract available

  120. MEKANIMITDEE P, Morasert T, Patumanond J, Phinyo P, et al
    The MAGENTA model for individual prediction of in-hospital mortality in chronic obstructive pulmonary disease with acute exacerbation in resource-limited countries: A development study.
    PLoS One. 2021;16:e0256866.
    PubMed     Abstract available

  121. LIAO P, Vajdic C, Trollor J, Reppermund S, et al
    Prevalence and incidence of physical health conditions in people with intellectual disability - a systematic review.
    PLoS One. 2021;16:e0256294.
    PubMed     Abstract available

  122. AGUILANIU B, Hess D, Kelkel E, Briault A, et al
    A machine learning approach to predict extreme inactivity in COPD patients using non-activity-related clinical data.
    PLoS One. 2021;16:e0255977.
    PubMed     Abstract available

  123. ADLER D, Bailly S, Soccal PM, Janssens JP, et al
    Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry.
    PLoS One. 2021;16:e0256230.
    PubMed     Abstract available

  124. PERCOPO CM, McCullough M, Limkar AR, Druey KM, et al
    Impact of controlled high-sucrose and high-fat diets on eosinophil recruitment and cytokine content in allergen-challenged mice.
    PLoS One. 2021;16:e0255997.
    PubMed     Abstract available

  125. KIM IS, Choi YJ, Choi EY, Min PK, et al
    Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
    PLoS One. 2021;16:e0258770.
    PubMed     Abstract available

  126. DDUNGU A, Semitala FC, Castelnuovo B, Sekaggya-Wiltshire C, et al
    Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country.
    PLoS One. 2021;16:e0256121.
    PubMed     Abstract available

  127. PEREZ CHACON G, Fathima P, Jones M, Barnes R, et al
    Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.
    PLoS One. 2021;16:e0260388.
    PubMed     Abstract available

  128. RIMMER C, Hetelekides S, Eliseeva SI, Georas SN, et al
    Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge.
    PLoS One. 2021;16:e0260706.
    PubMed     Abstract available

  129. QADEER A, Parikh PB, Ramkishun CA, Tai J, et al
    Impact of chronic obstructive pulmonary disease on survival and neurologic outcomes in adults with in-hospital cardiac arrest.
    PLoS One. 2021;16:e0259698.
    PubMed     Abstract available

  130. STAVEM K, Johannessen A, Nielsen R, Gulsvik A, et al
    Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time.
    PLoS One. 2021;16:e0260416.
    PubMed     Abstract available

  131. KERAMAT SA, Alam K, Rana RH, Chowdhury R, et al
    Obesity and the risk of developing chronic diseases in middle-aged and older adults: Findings from an Australian longitudinal population survey, 2009-2017.
    PLoS One. 2021;16:e0260158.
    PubMed     Abstract available

  132. SPILLING CA, Dhillon MK, Burrage DR, Ruickbie S, et al
    Factors affecting brain structure in smoking-related diseases: Chronic Obstructive Pulmonary Disease (COPD) and coronary artery disease.
    PLoS One. 2021;16:e0259375.
    PubMed     Abstract available

  133. SANDER B, Finkelstein Y, Lu H, Nagamuthu C, et al
    Healthcare cost attributable to bronchiolitis: A population-based cohort study.
    PLoS One. 2021;16:e0260809.
    PubMed     Abstract available

  134. LEE MF, Chiang CH, Lin SJ, Wu CS, et al
    Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.
    PLoS One. 2021;16:e0261333.
    PubMed     Abstract available

  135. CHEN H, Liu X, Gao X, Lv Y, et al
    Epidemiological evidence relating risk factors to chronic obstructive pulmonary disease in China: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0261692.
    PubMed     Abstract available

  136. NAKAMA C, Tabuchi T
    Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
    PLoS One. 2021;16:e0260154.
    PubMed     Abstract available

  137. GOTTLIEB J, Verleden GM, Perchl M, Valtin C, et al
    Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
    PLoS One. 2021;16:e0260881.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.